These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15090261)

  • 1. Anti-atherosclerotic effects of vitamin E--myth or reality?
    Munteanu A; Zingg JM; Azzi A
    J Cell Mol Med; 2004; 8(1):59-76. PubMed ID: 15090261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of alpha-tocopherol in preventing disease.
    Azzi A
    Eur J Nutr; 2004 Mar; 43 Suppl 1():I/18-25. PubMed ID: 15052495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E 80th anniversary: a double life, not only fighting radicals.
    Ricciarelli R; Zingg JM; Azzi A
    IUBMB Life; 2001 Jul; 52(1-2):71-6. PubMed ID: 11795598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin E-related inhibition of monocyte 5-lipoxygenase and cardiovascular outcome in maintenance hemodialysis patients.
    Manca-di-Villahermosa S; Giacominelli-Stuffler R; Angelucci CB; Taccone-Gallucci M; Maccarrone M
    Recent Pat Inflamm Allergy Drug Discov; 2011 Sep; 5(3):229-40. PubMed ID: 21843148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 24R,25-(OH)(2)D(3) mediates its membrane receptor-dependent effects on protein kinase C and alkaline phosphatase via phospholipase A(2) and cyclooxygenase-1 but not cyclooxygenase-2 in growth plate chondrocytes.
    Schwartz Z; Sylvia VL; Del Toro F; Hardin RR; Dean DD; Boyan BD
    J Cell Physiol; 2000 Mar; 182(3):390-401. PubMed ID: 10653606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitamin E on the development of atherosclerosis.
    Ozer NK; Azzi A
    Toxicology; 2000 Aug; 148(2-3):179-85. PubMed ID: 10962137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E).
    Carr AC; Zhu BZ; Frei B
    Circ Res; 2000 Sep; 87(5):349-54. PubMed ID: 10969031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages.
    Baker CS; Hall RJ; Evans TJ; Pomerance A; Maclouf J; Creminon C; Yacoub MH; Polak JM
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):646-55. PubMed ID: 10073969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific cellular responses to alpha-tocopherol.
    Azzi A; Breyer I; Feher M; Pastori M; Ricciarelli R; Spycher S; Staffieri M; Stocker A; Zimmer S; Zingg JM
    J Nutr; 2000 Jul; 130(7):1649-52. PubMed ID: 10867030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
    Belton OA; Duffy A; Toomey S; Fitzgerald DJ
    Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 80th anniversary of vitamin E: beyond its antioxidant properties.
    Ricciarelli R; Zingg JM; Azzi A
    Biol Chem; 2002; 383(3-4):457-65. PubMed ID: 12033435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E mediated response of smooth muscle cell to oxidant stress.
    Azzi A; Boscoboinik D; Clément S; Ozer N; Ricciarelli R; Stocker A
    Diabetes Res Clin Pract; 1999 Sep; 45(2-3):191-8. PubMed ID: 10588372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E (alpha-tocopherol) attenuates cyclo-oxygenase 2 transcription and synthesis in immortalized murine BV-2 microglia.
    Egger T; Schuligoi R; Wintersperger A; Amann R; Malle E; Sattler W
    Biochem J; 2003 Mar; 370(Pt 2):459-67. PubMed ID: 12429020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 inhibitors and atherosclerosis.
    Belton O; Fitzgerald D
    J Am Coll Cardiol; 2003 May; 41(10):1820-2. PubMed ID: 12767670
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-antioxidant activities of vitamin E.
    Zingg JM; Azzi A
    Curr Med Chem; 2004 May; 11(9):1113-33. PubMed ID: 15134510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of vitamin E inhibition of cyclooxygenase activity in macrophages from old mice: role of peroxynitrite.
    Beharka AA; Wu D; Serafini M; Meydani SN
    Free Radic Biol Med; 2002 Mar; 32(6):503-11. PubMed ID: 11958951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice.
    Burleigh ME; Babaev VR; Oates JA; Harris RC; Gautam S; Riendeau D; Marnett LJ; Morrow JD; Fazio S; Linton MF
    Circulation; 2002 Apr; 105(15):1816-23. PubMed ID: 11956125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E and vascular homeostasis: implications for atherosclerosis.
    Keaney JF; Simon DI; Freedman JE
    FASEB J; 1999 Jun; 13(9):965-75. PubMed ID: 10336880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice.
    Rott D; Zhu J; Burnett MS; Zhou YF; Zalles-Ganley A; Ogunmakinwa J; Epstein SE
    J Am Coll Cardiol; 2003 May; 41(10):1812-9. PubMed ID: 12767669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability.
    Cipollone F; Prontera C; Pini B; Marini M; Fazia M; De Cesare D; Iezzi A; Ucchino S; Boccoli G; Saba V; Chiarelli F; Cuccurullo F; Mezzetti A
    Circulation; 2001 Aug; 104(8):921-7. PubMed ID: 11514380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.